McGill_2013_Diabetes.Care_36_237

Reference

Title : Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study - McGill_2013_Diabetes.Care_36_237
Author(s) : McGill JB , Sloan L , Newman J , Patel S , Sauce C , von Eynatten M , Woerle HJ
Ref : Diabetes Care , 36 :237 , 2013
Abstract : McGill_2013_Diabetes.Care_36_237
ESTHER : McGill_2013_Diabetes.Care_36_237
PubMedSearch : McGill_2013_Diabetes.Care_36_237
PubMedID: 23033241

Related information

Citations formats

McGill JB, Sloan L, Newman J, Patel S, Sauce C, von Eynatten M, Woerle HJ (2013)
Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study
Diabetes Care 36 :237

McGill JB, Sloan L, Newman J, Patel S, Sauce C, von Eynatten M, Woerle HJ (2013)
Diabetes Care 36 :237